Interventional
Allocation: Randomized, Endpoint Classification: Bio-availability Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver), Primary Purpose: Prevention
Serum 25(OH)D level
0, 1 day, 7 days, 14 days
Yes
Israel: Ministry of Health
No. 1-Version 1.
NCT01807845
January 2013
December 2013
Name | Location |
---|